Xilio Therapeutics XLO
NASDAQ XLO
$8.03 -0.40 (-4.74%)
At close: Oct 22, 2026 · 4:00 PM EDT

Xilio Therapeutics (XLO) Price to Sales (2025 - 2026)

Updated

Xilio Therapeutics' (XLO) Price to Sales stood at 2.90 in Q2 2026, down 33.7% from 4.37 a year earlier but up 12.8% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Xilio Therapeutics' Price to Sales came in at 1.71, down 75.2% from FY2024.

  • Across earlier years, Price to Sales came in at 6.89 in FY2024.
  • Quarterly Price to Sales has ranged from 1.71 in Q4 2025 to 5.83 in Q1 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 2.57 (Q1 2026), 1.71 (Q4 2025) and 3.82 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Xilio Therapeutics 155.24 Mn -372.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.90
Mar 31, 2026 2.57
Dec 31, 2025 1.71
Sep 30, 2025 3.82
Jun 30, 2025 4.37
Mar 31, 2025 5.83
API Access

Xilio Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=XLO&period=max&api_key=YOUR_API_KEY